Skip to main content
Caplight Logo









Alida Biosciences

Alida Biosciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.alidabio.com/

Last Round

Series A

Jun 12, 2024

Total Funding Raised

$19.02M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Alida Biosciences is a biotechnology company that develops innovative RNA biology technologies and tools to enhance human health by facilitating the discovery of new drugs and therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

epitranscriptomicsRNA modification analysisRNA sequencingNGSnext-generation sequencingRNA therapeuticsdrug discoverybioinformaticsprecision medicinebiotech reagentsassay kitsRNA profilingmolecular biology toolsepigenetics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alida Biosciences Comparables

Compare Alida Biosciences with similar companies based on industry and business-model similarity.

Alida Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lilac Biosciences Inc.
85%
Eclipsebio
82%
Wobble Genomics
80%

Alida Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 12, 2024
GrantJun 12, 2024
GrantMay 1, 2023
GrantSep 1, 2021

Key People

Founding team and executive leadership

Gudrun Stengel

CEO & Co-Founder

Founding Team

Alida Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 37% MoM, reaching 4.6K.

  • Apr 23, 2026

    Added Chameleon Science Pty, a biotech startup, as a customer.

Alida Biosciences Filings

Explore SEC and related filing metadata, where available.

Alida Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alida Biosciences's valuation, stock price, and market status.

Is Alida Biosciences a public or private company?

Alida Biosciences is a private company.

What is the current stock price of Alida Biosciences?

Alida Biosciences is a private company, so its shares have no public market price. Caplight tracks Alida Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Alida Biosciences worth (valuation)?

Valuation information for Alida Biosciences is not publicly available.

Can I buy Alida Biosciences stock?

Alida Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Alida Biosciences's last funding round?

Alida Biosciences's most recent funding round was Series A on June 12, 2024.

Who are the main investors in Alida Biosciences?

Key investors in Alida Biosciences include Genoa Ventures.

Will Alida Biosciences IPO soon?

No public IPO plans have been announced for Alida Biosciences.

How can I track Alida Biosciences secondary market activity?

Caplight tracks bids, offers, and trades in Alida Biosciences's shares on secondary markets.

Firmographic Details

HeadquartersSan Diego, California
Employee Range16
Year Founded2020
Last FundingJun 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?